

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer wi...


July 2 (Reuters) - AstraZeneca has entered into a deal worth up to $1.77 billion with CSPC Pharmaceutical Group to discover and develop experimenta...


(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.